Deutsche Bank
BEAM icon

Deutsche Bank’s Beam Therapeutics BEAM Stock Holding History

Deutsche Bank’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.57M Buy
104,091
+16,950
+19% +$512K ﹤0.01% 1549
2026
Q1 		$2.08M Buy
87,141
+9,577
+12% +$266K ﹤0.01% 1760
2025
Q4 		$2.15M Buy
77,564
+4,649
+6% +$119K ﹤0.01% 1756
2025
Q3 		$1.77M Buy
72,915
+8,127
+13% +$162K ﹤0.01% 1858
2025
Q2 		$1.1M Sell
64,788
-11,523
-15% -$201K ﹤0.01% 2038
2025
Q1 		$1.49M Buy
76,311
+8,803
+13% +$231K ﹤0.01% 1939
2024
Q4 		$1.67M Buy
67,508
+23,871
+55% +$609K ﹤0.01% 1960
2024
Q3 		$1.07M Sell
43,637
-818,356
-95% -$21.1M ﹤0.01% 2079
2024
Q2 		$20.2M Buy
861,993
+801,238
+1,319% +$19.7M 0.01% 817
2024
Q1 		$2.01M Buy
60,755
+3,800
+7% +$118K ﹤0.01% 1654
2023
Q4 		$1.55M Buy
56,955
+156
+0.3% +$3.88K ﹤0.01% 1809
2023
Q3 		$1.37M Buy
56,799
+4,381
+8% +$117K ﹤0.01% 1549
2023
Q2 		$1.67M Sell
52,418
-13,612
-21% -$442K ﹤0.01% 1709
2023
Q1 		$2.02M Buy
66,030
+13,629
+26% +$538K ﹤0.01% 1684
2022
Q4 		$2.05M Buy
52,401
+2,046
+4% +$91.6K ﹤0.01% 1641
2022
Q3 		$2.4M Buy
50,355
+1,335
+3% +$76.2K ﹤0.01% 1534
2022
Q2 		$1.9M Buy
49,020
+3,816
+8% +$152K ﹤0.01% 1794
2022
Q1 		$2.59M Sell
45,204
-2,966
-6% -$195K ﹤0.01% 1741
2021
Q4 		$3.84M Buy
48,170
+426
+0.9% +$36.5K ﹤0.01% 1597
2021
Q3 		$4.15M Buy
47,744
+16,650
+54% +$1.67M ﹤0.01% 1617
2021
Q2 		$4M Sell
31,094
-26,473
-46% -$2.11M ﹤0.01% 1676
2021
Q1 		$4.61M Buy
57,567
+26,762
+87% +$2.55M ﹤0.01% 1592
2020
Q4 		$2.51M Buy
30,805
+11,571
+60% +$569K ﹤0.01% 1792
2020
Q3 		$473K Buy
19,234
+13,058
+211% +$324K ﹤0.01% 2670
2020
Q2 		$173K Buy
6,176
+1,776
+40% +$38.3K ﹤0.01% 3210
2020
Q1 		$79K Buy
+4,400
New +$95.6K ﹤0.01% 3347

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Deutsche Bank's BEAM Position: Q2 2026 in Review

Deutsche Bank increased its Beam Therapeutics (BEAM) stake by 19% in Q2 2026, buying an estimated $512K and bringing the position to 104,091 shares worth $3.57M. The position accounts for ﹤0.01% of the portfolio, ranked #1549.

Deutsche Bank first reported a position in BEAM in Q1 2020 and has held it in 26 quarters since. The position peaked at $20.2M in Q2 2024. 278 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Deutsche Bank held 104,091 shares of Beam Therapeutics worth $3.57M as of Q2 2026.
  • Deutsche Bank bought 16,950 Beam Therapeutics shares in Q2 2026, an estimated $512K.
  • Beam Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1549 holding.
  • Deutsche Bank first reported a position in Beam Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • Deutsche Bank's Beam Therapeutics position peaked at $20.2M in Q2 2024.
  • 278 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.